Valdecoxib: A review
- 31 March 2003
- journal article
- review article
- Published by Elsevier in Clinical Therapeutics
- Vol. 25 (3) , 817-851
- https://doi.org/10.1016/s0149-2918(03)80110-8
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Valdecoxib, a cyclooxygenase-2-specific inhibitor, is effective in treating primary dysmenorrheaPublished by Wolters Kluwer Health ,2002
- Gastrointestinal Safety of Coxibs and Outcomes Studies: What's the Verdict?Journal of Pain and Symptom Management, 2002
- Efficacy of valdecoxib versus naproxen sodium in primary dysmenorrheaPublished by Wolters Kluwer Health ,2002
- ValdecoxibDrugs, 2002
- The cyclooxygenase (COX)-2 specific inhibitor valdecoxib effectively treats primary dysmenorrhea.Fertility and Sterility, 2001
- Reduced incidence of gastroduodenal ulcers with valdecoxib compared to ibuprofen and diclofenac in patients with osteoarthritis: A multicenter trialGastroenterology, 2001
- Mechanism of Action of Acetaminophen: Is There a Cyclooxygenase 3?Clinical Infectious Diseases, 2000
- Gastrointestinal Toxicity With Celecoxib vs Nonsteroidal Anti-inflammatory Drugs for Osteoarthritis and Rheumatoid ArthritisJAMA, 2000
- Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agentsNature, 1996
- American college of rheumatology preliminary definition of improvement in rheumatoid arthritisArthritis & Rheumatism, 1995